A private mutual-aid platform partners fully with a leading Japanese regenerative medicine company, focusing on health value transformation and public welfare initiatives
Press Release Summary
Wanyi Club announced a partnership with Japan Waton Co., Ltd., securing an initial allocation of NT$500 million dedicated to developing the Taiwan market. Wanyi will focus on marketing, user acquisition, and coordination of public welfare initiatives, while Waton will take full responsibility for medical solutions and technical implementation. Through this collaboration, both parties aim to achieve deep integration between scientific research and market operations.
Wanyi Club officially announced today that it has entered into a deep strategic partnership with Japan Waton Co., Ltd., a renowned regenerative medicine institution headquartered in Ginza, Tokyo. Under the agreement, Wanyi Club will exclusively focus on promoting Waton’s biomedical projects in the Taiwan market, including marketing, user acquisition, and public welfare implementation, without involvement in technical promotion or execution of medical solutions. To accelerate brand development and market expansion, Waton Co., Ltd. has allocated an initial NT$500 million as a dedicated market operation fund. This agreement marks a significant integration of a private mutual-aid promotion model with world-class scientific research capabilities, and is expected to have a long-term impact on the adoption of preventive medicine across the Asia-Pacific region.
Cross-Border Collaboration: A “Dual-Drive” Model of Research and Market
The core of this strategic partnership lies in a highly specialized division of responsibilities. As a leader in Japan’s regenerative medicine sector, Waton Co., Ltd. will focus its resources on the research and development of advanced technologies such as stem cells and exosomes, as well as collaboration with international academic institutions. On the market side, Wanyi Club will leverage its strong community network and operational experience to handle brand education, channel development, and user acquisition in Taiwan.
A spokesperson from Wanyi Club noted that this model breaks away from the traditional burden faced by biomedical companies of managing both R&D and sales simultaneously. Through this collaboration, Waton can concentrate on its strengths in medical technology and professional implementation, while Wanyi ensures efficient market operations supported by credible technical expertise—creating a positive cycle of “professional R&D and efficient promotion.”
Initial NT$500 Million Allocation: Building Taiwan’s Health Ecosystem
As a key component of the agreement, the NT$500 million funding from Waton will primarily be used for infrastructure development and brand expansion in Taiwan. The funds will support the establishment of standardized marketing systems, training of professional health advocacy teams, and the development of offline service centers across Taiwan.
In addition, the funding will enable Wanyi Club to launch large-scale health awareness campaigns and community engagement initiatives. Over the next year, Wanyi plans to expand Waton’s brand presence and user reach in Taiwan through both online and offline multi-channel marketing, while all technical applications and medical solutions will be handled by Waton and relevant professional institutions. Wanyi emphasized that market promotion should not be limited to commercial growth metrics, but should also enhance public understanding of preventive medicine through high-quality health services.
Public Welfare First: Fulfilling Corporate Social Responsibility
Beyond commercial collaboration, Wanyi Club has explicitly taken on the role of the primary organizer of public welfare initiatives. Wanyi advocates making technological advancements accessible to the public, allowing regenerative medicine—traditionally considered high-barrier—to benefit a wider population through public welfare mechanisms.
Both parties plan to launch a nationwide public program titled “Cellular Respiration” by the end of 2025. This initiative will combine Waton’s professional medical resources with Wanyi’s volunteer network. Wanyi will be responsible for organizing activities and attracting participants, focusing on promoting preventive medicine awareness among elderly and sub-healthy populations. Wanyi believes that public welfare is not a supplementary effort, but the foundation of platform credibility. The trust built through initiatives is considered a core competitive advantage that cannot be replaced by conventional marketing methods.
Future Outlook: Defining a New Standard for Mutual-Aid Platforms
Since its establishment in early 2025, Wanyi Club has been committed to connecting high-quality projects. Securing this partnership and the initial NT$500 million funding from Waton demonstrates the viability of its “light structure, strong execution” model.
Moving forward, Wanyi will continue optimizing its community-driven growth mechanisms and improving resource integration through digital management tools. Meanwhile, Waton will continue introducing cutting-edge research outcomes guided by Nobel Prize laureates. Both parties believe that Taiwan, as a key hub for biomedical innovation in the Asia-Pacific region, will serve as an important benchmark for future global expansion.
About Wanyi Club
Wanyi Club is an independent third-party mutual-aid platform focused on market promotion, resource integration, and public welfare for high-quality projects. Guided by its mission, “United as one, moving forward together for mutual benefit,” the club leverages community power to achieve shared value and promote health awareness.
